Safety net hospitals in California are using a car manufacturer's model to improve efficiency while saving on care costs.
The car maker Toyota has an extremely efficient and organized model in place that is now improving care delivery at safety net hospitals in the nation, like Harbor-UCLA. While private hospitals have already implemented this model, it's a novel idea for safety net hospitals that cater to the low-income population who now have insurance coverage thanks to the Affordable Care Act.
While some critics are skeptical on how well a car manufacturer's process could translate into healthcare, supporters have complete faith in the model. Analysis by the California HealthCare Foundation, which has helped fund the project at Harbor-UCLA and 4 San Francisco Bay Area hospitals—San Francisco General Hospital, Contra Costa Regional Medical Center, San Mateo Medical Center, and the Alameda Health System—says that the model has had direct, positive results, such as reducing the time patients spent at the hospital and decreasing medication errors, while saving money.
Read more at Kaiser Health News.
Standard Criteria for Loss of Ambulation Needed in DMD
April 19th 2024A recent study suggests the differences between ambulation definitions for patients with Duchenne muscular dystrophy (DMD) can impact the identification of ambulant vs nonambulant individuals, and standard criteria across settings are needed.
Read More
Navigating Health Literacy, Social Determinants, and Discrimination in National Health Plans
February 13th 2024On this episode of Managed Care Cast, we're talking with the authors of a study published in the February 2024 issue of The American Journal of Managed Care® about their findings on how health plans can screen for health literacy, social determinants of health, and perceived health care discrimination.
Listen
An Overview of Health Care and Pharmaceutical Trends, 2023-2024
April 19th 2024Douglas M. Long, BA, MBA, was featured as the keynote speaker on the closing day of The Academy of Managed Care Pharmacy 2024 annual meeting, with a session dedicated to surveying the health care and pharmaceutical trends of the last year.
Read More
Drs Raymond Thertulien, Joseph Mikhael on Racial Disparities in Multiple Myeloma Care Access
December 28th 2023In the wake of the 2023 American Society of Hematology Annual Meeting and Exposition, Raymond Thertulien, MD, PhD, of Novant Health, and Joseph Mikhael, MD, MEd, FRCPC, FACP, chief medical officer of the International Myeloma Foundation, discussed health equity research highlights from the meeting and drivers of racial disparities in multiple myeloma outcomes.
Listen
Real-World Study Reveals Key Insights Into DLBCL Treatment Patterns, Outcomes
April 18th 2024A recent study offers valuable insights into the characteristics, treatment patterns, and outcomes of diffuse large B-cell lymphoma (DLBCL) in patients across different lines of therapy, providing a look into the landscape of DLBCL management.
Read More